765 related articles for article (PubMed ID: 24519981)
21. Soluble Aβ aggregates can inhibit prion propagation.
Sarell CJ; Quarterman E; Yip DC; Terry C; Nicoll AJ; Wadsworth JDF; Farrow MA; Walsh DM; Collinge J
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29142106
[TBL] [Abstract][Full Text] [Related]
22. Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns.
Minaki H; Sasaki K; Honda H; Iwaki T
Neuropathology; 2009 Oct; 29(5):536-42. PubMed ID: 19389076
[TBL] [Abstract][Full Text] [Related]
23. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein.
Balducci C; Beeg M; Stravalaci M; Bastone A; Sclip A; Biasini E; Tapella L; Colombo L; Manzoni C; Borsello T; Chiesa R; Gobbi M; Salmona M; Forloni G
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2295-300. PubMed ID: 20133875
[TBL] [Abstract][Full Text] [Related]
24. Liquid and Hydrogel Phases of PrP
Kostylev MA; Tuttle MD; Lee S; Klein LE; Takahashi H; Cox TO; Gunther EC; Zilm KW; Strittmatter SM
Mol Cell; 2018 Nov; 72(3):426-443.e12. PubMed ID: 30401430
[TBL] [Abstract][Full Text] [Related]
25. Preferential Recruitment of Conformationally Distinct Amyloid-β Oligomers by the Intrinsically Disordered Region of the Human Prion Protein.
Madhu P; Mukhopadhyay S
ACS Chem Neurosci; 2020 Jan; 11(1):86-98. PubMed ID: 31808343
[TBL] [Abstract][Full Text] [Related]
26. Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice.
Ordóñez-Gutiérrez L; Torres JM; Gavín R; Antón M; Arroba-Espinosa AI; Espinosa JC; Vergara C; Del Río JA; Wandosell F
Neurobiol Aging; 2013 Dec; 34(12):2793-804. PubMed ID: 23831375
[TBL] [Abstract][Full Text] [Related]
27. Single-molecule imaging reveals that small amyloid-β1-42 oligomers interact with the cellular prion protein (PrP(C)).
Ganzinger KA; Narayan P; Qamar SS; Weimann L; Ranasinghe RT; Aguzzi A; Dobson CM; McColl J; St George-Hyslop P; Klenerman D
Chembiochem; 2014 Nov; 15(17):2515-21. PubMed ID: 25294384
[TBL] [Abstract][Full Text] [Related]
28. The pathogenesis of soluble PrP fragments containing Aβ binding sites.
Li B
Virus Res; 2016 Jan; 211():194-8. PubMed ID: 26528810
[TBL] [Abstract][Full Text] [Related]
29. The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers.
Younan ND; Sarell CJ; Davies P; Brown DR; Viles JH
FASEB J; 2013 May; 27(5):1847-58. PubMed ID: 23335053
[TBL] [Abstract][Full Text] [Related]
30. Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregates.
Venkataramani V; Wirths O; Budka H; Härtig W; Kovacs GG; Bayer TA
J Alzheimers Dis; 2012; 29(2):361-71. PubMed ID: 22232007
[TBL] [Abstract][Full Text] [Related]
31. Unaltered prion protein expression in Alzheimer disease patients.
Saijo E; Scheff SW; Telling GC
Prion; 2011; 5(2):109-16. PubMed ID: 21654203
[TBL] [Abstract][Full Text] [Related]
32. Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease.
Haas LT; Salazar SV; Kostylev MA; Um JW; Kaufman AC; Strittmatter SM
Brain; 2016 Feb; 139(Pt 2):526-46. PubMed ID: 26667279
[TBL] [Abstract][Full Text] [Related]
33. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy.
König AS; Rösener NS; Gremer L; Tusche M; Flender D; Reinartz E; Hoyer W; Neudecker P; Willbold D; Heise H
J Biol Chem; 2021; 296():100499. PubMed ID: 33667547
[TBL] [Abstract][Full Text] [Related]
34. Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.
Nygaard HB; Strittmatter SM
Arch Neurol; 2009 Nov; 66(11):1325-8. PubMed ID: 19901162
[TBL] [Abstract][Full Text] [Related]
35. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
[TBL] [Abstract][Full Text] [Related]
36. The prion protein as a receptor for amyloid-beta.
Kessels HW; Nguyen LN; Nabavi S; Malinow R
Nature; 2010 Aug; 466(7308):E3-4; discussion E4-5. PubMed ID: 20703260
[TBL] [Abstract][Full Text] [Related]
37. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
38. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.
Resenberger UK; Harmeier A; Woerner AC; Goodman JL; Müller V; Krishnan R; Vabulas RM; Kretzschmar HA; Lindquist S; Hartl FU; Multhaup G; Winklhofer KF; Tatzelt J
EMBO J; 2011 May; 30(10):2057-70. PubMed ID: 21441896
[TBL] [Abstract][Full Text] [Related]
39. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
[TBL] [Abstract][Full Text] [Related]
40. Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.
Cohen ML; Kim C; Haldiman T; ElHag M; Mehndiratta P; Pichet T; Lissemore F; Shea M; Cohen Y; Chen W; Blevins J; Appleby BS; Surewicz K; Surewicz WK; Sajatovic M; Tatsuoka C; Zhang S; Mayo P; Butkiewicz M; Haines JL; Lerner AJ; Safar JG
Brain; 2015 Apr; 138(Pt 4):1009-22. PubMed ID: 25688081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
